Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
My New Book is Now A Best Seller | Order Now My New Book is Now A Best Seller | Order Now

Bextra's Risks Higher Than Vioxx

  • November 10, 2004

Not a surprise to find out Pfizer's Bextra, the drug that replaced Vioxx in late September as the current inflammatory of choice among conventional physicians, was just as problematic after a prominent cardiologist announced a pooled analysis of clinical trial results showed patients taking the drug were twice as likely to have a heart attack or stroke as those taking a placebo. In fact, an analysis of nearly 6,000 patients showed the risk of Bextra to be higher than Vioxx. Although...